We are live on ! Find out more
CCM

Camber Capital Management Portfolio holdings

AUM $1.07B
1-Year Est. Return 8.19%
This Fund
S&P 500
This Quarter Est. Return
+8.51%
1 Year Est. Return
-8.19%
3 Year Est. Return
+26.6%
5 Year Est. Return
+54.57%
10 Year Est. Return
+164.72%
AUM
$2.91B
AUM Growth
+$65M
Cap. Flow
-$72.2M
Cap. Flow %
-2.48%
Top 10 Hldgs %
62.63%
Holding
44
New
12
Increased
5
Reduced
8
Closed
12

Top Buys

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$99.7M
2
MRK icon
Merck
MRK
+$77.3M
3
GILD icon
Gilead Sciences
GILD
+$64.5M
4
IONS icon
Ionis Pharmaceuticals
IONS
+$55.8M
5
WELL icon
Welltower
WELL
+$54.4M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$184M
2
BHC icon
Bausch Health
BHC
+$88.4M
3
SRPT icon
Sarepta Therapeutics
SRPT
+$68.2M
4
MYGN icon
Myriad Genetics
MYGN
+$56.8M
5
BIIB icon
Biogen
BIIB
+$49M

Sector Composition

Rank Sector Weight
1 Healthcare 73.16%
2 Technology 8.53%
3 Real Estate 3.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$784B
$396M 13.6%
+1,000,000
New +$386M
CHNG
2
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$249M 8.53%
11,250,000
-1,750,000
-13% -$40.5M
WBA
3
DELISTED
Walgreens Boots Alliance
WBA
$206M 7.06%
3,750,000
+750,000
+25% +$37.1M
UHS icon
4
Universal Health Services
UHS
$9.88B
$187M 6.41%
1,400,000
– –
VTRS icon
5
Viatris
VTRS
$20.7B
$168M 5.75%
12,000,000
– –
THC icon
6
Tenet Healthcare
THC
$21.8B
$156M 5.35%
3,000,000
– –
HCA icon
7
HCA Healthcare
HCA
$85.7B
$146M 5.01%
775,000
-75,000
-9% -$13.2M
PRGO icon
8
Perrigo
PRGO
$1.43B
$113M 3.89%
2,800,000
-200,000
-7% -$8.58M
ALKS icon
9
Alkermes
ALKS
$8.39B
$105M 3.59%
5,600,000
-1,150,000
-17% -$23.5M
ZBH icon
10
Zimmer Biomet
ZBH
$18.4B
$100M 3.43%
+643,750
New +$99.7M
MYGN icon
11
Myriad Genetics
MYGN
$507M
$91.3M 3.13%
3,000,000
-2,000,000
-40% -$56.8M
GSK icon
12
GSK
GSK
$104B
$89.2M 3.06%
2,000,000
-800,000
-29% -$36.3M
IRWD icon
13
Ironwood Pharmaceuticals
IRWD
$614M
$83.8M 2.88%
7,500,000
– –
MRK icon
14
Merck
MRK
$321B
$77.1M 2.65%
+1,048,000
New +$77.3M
BKD icon
15
Brookdale Senior Living
BKD
$3.49B
$75.6M 2.6%
12,500,000
+300,000
+2% +$1.61M
GILD icon
16
Gilead Sciences
GILD
$163B
$64.6M 2.22%
+1,000,000
New +$64.5M
TEVA icon
17
Teva Pharmaceuticals
TEVA
$41.2B
$63.5M 2.18%
5,500,000
+1,000,000
+22% +$11.5M
WELL icon
18
Welltower
WELL
$170B
$58M 1.99%
+810,000
New +$54.4M
VTR icon
19
Ventas
VTR
$44.7B
$48M 1.65%
+900,000
New +$46.2M
COLL icon
20
Collegium Pharmaceutical
COLL
$1.17B
$47.4M 1.63%
2,000,000
– –
IONS icon
21
Ionis Pharmaceuticals
IONS
$8.81B
$45M 1.54%
+1,000,000
New +$55.8M
OSUR icon
22
OraSure Technologies
OSUR
$273M
$41.7M 1.43%
3,575,000
+325,000
+10% +$3.98M
INCY icon
23
Incyte
INCY
$24.9B
$40.6M 1.39%
+500,000
New +$42.7M
NKTR icon
24
Nektar Therapeutics
NKTR
$2.41B
$40M 1.37%
133,333
-33,334
-20% -$10.4M
RETA
25
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$39.9M 1.37%
+400,000
New +$46.7M
1
2

Similar funds

PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
NRD
Nebula Research & Development New York $1.17B AUM 15.19% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return
CCP
Camelot Capital Partners Laguna Beach, California $686M AUM 163.55% 1-Year Est. Return

Camber Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Camber Capital Management held 44 positions worth $2.91B, up 2.3% from $2.85B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Camber Capital Management's Q1 2021 filing shows 12 new, 5 increased, 8 reduced and 12 closed positions. Its largest new stake was Zimmer Biomet: 643,750 shares worth $100M. The largest sale was Alexion Pharmaceuticals, an estimated $184M.

By sector, the portfolio is most concentrated in Healthcare at 73% of assets, down from 75% a quarter earlier, followed by Technology and Real Estate.

  • Camber Capital Management's largest Q1 2021 buy was Zimmer Biomet: 643,750 shares worth $100M.
  • Camber Capital Management added most to Walgreens Boots Alliance in Q1 2021, an estimated $37.1M increase.
  • Camber Capital Management's biggest Q1 2021 reduction was Myriad Genetics, cutting an estimated $56.8M.
  • Camber Capital Management fully exited Alexion Pharmaceuticals in Q1 2021, selling an estimated $184M.
  • Camber Capital Management's ten largest holdings make up 63% of its $2.91B portfolio in Q1 2021.
  • Camber Capital Management opened 12 new positions and closed 12 in Q1 2021.
  • Camber Capital Management's portfolio value rose 2.3% quarter-over-quarter to $2.91B.

Based on Camber Capital Management's 13F filing for Q1 2021, filed 17 May 2021.